ARTV

Artiva BiotherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$7.62

Analysis reference price unavailable

Analysis 2025-11-21 · RankAlpha Sentiment AI

Most likely

Base case

55%

Probability

Target price

$4.76

Analysis reference price unavailable

Analysis 2025-11-21 · RankAlpha Sentiment AI

B-

Bear case

25%

Probability

Target price

$2.54

Analysis reference price unavailable

Analysis 2025-11-21 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-11-21

AI commentary

Market tone is cautious-to-bearish with heightened focus on near-term data and cash runway; recent price action shows pressure and elevated volume on down days [#News-2025-11-20]. Analyst discourse centers on binary clinical outcomes and dilution risk rather than broad optimism [#AnalystNotes].

RankAlpha Sentiment AI - 2025-11-21

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

-catalystPartnership or acquisition interestHigh impact

Strategic collaboration or M&A by a larger immuno-oncology player could re-rate shares if announced; probability limited but payoff high [#IR-press].

2026-03-31eventClinical data readouts for NK cell therapy candidatesHigh impact

Upcoming or recent clinical data readouts from Artiva's allogeneic NK programs could drive large binary moves if efficacy/safety materially surprise [#10-Qp31], [#PR-2025-08-14].

2026-06-30catalystCash runway / financing needHigh impact

Biotech firms at this stage often require equity raises; a dilutive financing announcement would likely pressure the share price [#10-Qp12].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-11-21 • Updated nightlySource: Internal modelMethodology